The story has been corrected to say that certification from New York is for AssureRx's laboratory not its GeneSightRx test.
NEW YORK (GenomeWeb News) – The New York State Department of Health has certified AssureRx's laboratory, allowing residents in the state access to the company's pharmacogenomic test, GeneSightRx.
As a result of the approval, the Mason, Ohio-based company's laboratory is certified to analyze DNA samples for pharmacogenomic testing in all 50 states.
GeneSightRx is for helping determine which psychiatric drugs may be most effective for a patient. The test was launched in late 2009 and combines pharmacogenomic data from scientific and clinical publications, information from drug labels, and the patient's genetic profile. A cheek swab is taken from a patient then analyzed at AssureRx's CLIA-certified laboratory.
As GenomeWeb Daily News' sister publication Pharmacogenomics Reporter said last week, AssureRx has made improvements to the test by adding new therapies on the test panel and launching a mobile device application to give doctors greater flexibility in ordering and viewing test results.